Literature DB >> 6243991

Inhibition kinetics of three R-factor-mediated beta-lactamases by a new beta-lactam sulfone (CP 45899).

R Labia, V Lelievre, J Peduzzi.   

Abstract

A new beta-lactam sulfone, CP 45899, has been proved to be a time-dependent irreversible inhibitor of three R-factor-mediated beta-lactamases (penicillin amido-beta-lactamhydrolase, EC 3.5.2.6): TEM-1 (pI = 5.4), TEM-2 (pI = 5.6) and Pitton's type 2 (pI = 7.7). This inhibition occurs in two principal steps: (1) formation of a reversible enzyme-inhibitor complex (characterized by a Ki); (2) evolution of this complex into one, or more, inactive protein(s) (kinact). With the three beta-lactamases CP 45899 shows, respectively, Ki of 0.9, 0.8 and 1.8 microM and kinact of 1.2 . 10(-3), 0.8 . 10(-3) and 1 . 10(-3) s-1; the turnover numbers are: 525, 2280 and 1220. These results are compared to those previously obtained with clavulanic acid.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6243991     DOI: 10.1016/0005-2744(80)90071-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  14 in total

1.  High-pressure liquid chromatographic assay of sulbactam in plasma, urine, and tissue.

Authors:  R E Bawdon; P O Madsen
Journal:  Antimicrob Agents Chemother       Date:  1986-08       Impact factor: 5.191

2.  [Clinical significance of beta-lactamase inhibitors].

Authors:  D Adam
Journal:  Klin Wochenschr       Date:  1988-01-15

3.  Kinetic studies on inactivation of Citrobacter freundii cephalosporinase by sulbactam.

Authors:  A Yamaguchi; T Hirata; T Sawai
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

Review 4.  Antibiotic resistance in pathogenic and producing bacteria, with special reference to beta-lactam antibiotics.

Authors:  H Ogawara
Journal:  Microbiol Rev       Date:  1981-12

Review 5.  Sulbactam/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use.

Authors:  D M Campoli-Richards; R N Brogden
Journal:  Drugs       Date:  1987-06       Impact factor: 9.546

6.  Novel carbapenem derivative SF2103A: studies on the mode of beta-lactamase inactivation.

Authors:  A Yamaguchi; T Hirata; T Sawai
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

7.  Inhibition of the beta-lactamases of Branhamella catarrhalis by clavulanic acid and other inhibitors.

Authors:  T Farmer; C Reading
Journal:  Drugs       Date:  1986       Impact factor: 9.546

8.  Penetration of sulbactam and ampicillin into cerebrospinal fluid of infants and young children with meningitis.

Authors:  G Foulds; T J McBride; A K Knirsch; W J Rodriguez; W N Khan
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

9.  Kinetics of Sulbactam Hydrolysis by β-Lactamases, and Kinetics of β-Lactamase Inhibition by Sulbactam.

Authors:  Adam B Shapiro
Journal:  Antimicrob Agents Chemother       Date:  2017-11-22       Impact factor: 5.191

10.  Pharmacokinetics of sulbactam in humans.

Authors:  G Foulds; J P Stankewich; D C Marshall; M M O'Brien; S L Hayes; D J Weidler; F G McMahon
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.